Skip to content

Evaluation of Gait Performance in Children With Neuromuscular Diagnoses

Evaluation of the Gait Performance Measures 'Functional Mobility Scale' and 'Gillette Functional Assessment Questionnaire' in Children With Neuromuscular Diagnoses

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02237222
Enrollment
72
Registered
2014-09-11
Start date
2014-04-30
Completion date
2016-01-31
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychometrics of Two Translated Measurement Tools

Keywords

Outcome Assessment, Gait, Neuromuscular Diseases, Psychometrics, Clinical Assessment Tools

Brief summary

The aims of this project are to evaluate the psychometric properties of the German versions of the two performance questionnaires 'Functional Mobility Scale' (FMS) and 'Gillette Functional Assessment Questionnaire - walking scale' (GFAQ) in children between 6-18 years with a neuromuscular diagnosis.

Detailed description

The German versions of the two questionnaires 'Functional Mobility Scale' (FMS) and 'Gillette Functional Assessment Questionnaire - walking scale' (GFAQ) are evaluated in terms of construct validity, inter- and intra-rater reliability as well as responsiveness in children with a neuromuscular diagnosis, who absolve an inpatient stay in the rehabilitation center of the University Chilren's Hospital Zurich, Switzerland.

Interventions

Sponsors

University Children's Hospital, Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Neuromuscular diagnosis * Age: 6-18 years * Rehabilitation goal = improvement of walking abilities

Exclusion criteria

* Children's whose parents are not German-speaking

Design outcomes

Primary

MeasureTime frameDescription
Functional Mobility Scale (FMS)Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.The questionnaire is filled in independently by the parents, the primary nurse as well as the physiotherapist of each child.
Gillette Functional Assessment Questionnaire - Walking Scale (GFAQ)Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.The questionnaire is filled in independently by the parents, the primary nurse as well as the physiotherapist of each child.

Secondary

MeasureTime frameDescription
Global Rating Scale (GRS)Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.A global rating on the perceived change of the child's functional mobility over the rehabilitation period and whether this change is perceived as meaningful or not; on a 5-point Likert scale, scored by the parents and the physiotherapist.

Other

MeasureTime frameDescription
Functional Independence Measure for Children (WeeFIM)Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.The WeeFIM-Item Locomotion (Walking) is scored by the primary nurse.
10-Meter Walk Test (10MWT)Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.For the evaluation of the construct validity of the FMS and the GFAQ, the 10MWT comfortable speed as well as maximal speed will be performed shortly before discharge on a 14-meter long track with standardized instructions.
6-Minute walk test (6MinWT)Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.For the evaluation of the construct validity of the FMS and the GFAQ, the 6MinWT is performed shortly before discharge on a 30-meter long track with standardized instructions.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026